House of Commons photo

Crucial Fact

  • His favourite word was justice.

Last in Parliament May 2004, as Liberal MP for Etobicoke Centre (Ontario)

Won his last election, in 2000, with 56% of the vote.

Statements in the House

Health May 2nd, 2001

Mr. Speaker, if this keeps up we will need to put health warnings on the Leader of the Opposition.

As to access to information by consumers, naturally, whether they are seniors or others, we are talking about prescription drugs. The access to information is in the hands of the physicians who are doing the prescribing and in the hands of the pharmacists. That is the important thing.

The bottom line is that Health Canada wants to make sure Canadians have access to safe drugs and as much information as they or their doctors need, which has been the focus of our work. According to the Canadian Medical Association, we are doing a pretty darn good job.

Health May 2nd, 2001

Mr. Speaker, as a matter of fact, the hon. member's questions derive in large part from the Canadian Medical Association Journal . Today the editor of that journal, Dr. John Hoey, was quoted as saying:

Health Canada...does a remarkable job in getting warnings out. In fact Health Canada issued warnings, or had some data on this particular drug perhaps even in advance of the FDA in the U.S.

He went on to say:

In the past couple of days what we've done has been a little bit misinterpreted as a criticism of Health Canada, which it isn't.

Health May 2nd, 2001

Mr. Speaker, first, this is an odd line of inquiry from a leader and a party that during the election campaign questioned the need for Health Canada at all.

During the last year the hon. Leader of the Opposition was quoted as saying “I have to ask why we need to spend $1.2 billion and have a staff of over 3,000 in a federal department of health that does not administer a single hospital, pay a single nurse or fund a single surgical procedure”. That was his position then. I am glad to see the Leader of the Opposition understands the need for a strong Health Canada.

Health May 1st, 2001

Mr. Speaker, I was in the process of saying that the Canadian Medical Association Journal said that the first drug in relation to which it would put information on its website is a drug that last week the FDA issued a note on in terms of adverse drug reactions. It so happens that last week so did Health Canada. We acted the same week as the FDA in relation to that drug.

The point is that by whatever means it is important to get this information out to physicians and patients. Health Canada has accepted all the recommendations of the jury. We are committed to doing the job well.

Health May 1st, 2001

Mr. Speaker, the jury in the Vanessa Young case heard the long chronology of events. It heard that as long ago as 1995 and 1996 Health Canada was taking out pages in the Canadian Medical Association Journal to report on reactions in relation to the drug Prepulsid.

Let us put aside the arguments and get to the bottom line. The bottom line is the health and safety of Canadians. We welcome the CMA approach. We will look at it for our own website.

Let me point something out as a matter of interest. This morning the CMA announced that one of the drugs it will put on its website is a drug in relation to which—

Health May 1st, 2001

Mr. Speaker, Canadians' health and safety is the number one priority of our government.

Over the past three or four years, we have significantly increased available resources at Health Canada to manage this area, and we will continue to strengthen the system. Ensuring the safety of available drugs on the Canadian market is a key priority for us.

Health May 1st, 2001

Mr. Speaker, I have asked my officials to explore the possibility of Health Canada putting on its website for all Canadians including physicians any developments in relation to adverse drug reactions reported by the FDA or elsewhere in the world that is relevant to their use in Canada.

If it is found that is legally feasible, we will do it because we believe it is important to get up to the minute information available to Canadians, physicians and patients in relation to reactions to all medical drugs.

Health May 1st, 2001

Mr. Speaker, Canadians are justly proud of the quality of Health Canada's work in protecting their health and safety.

It is also clear that there is always room to improve. Last week a jury came back in an inquest in Toronto involving the tragic death of a 15 year old girl named Vanessa Young. That jury made recommendations on a variety of ways Health Canada can improve its surveillance of pharmaceutical drugs in the marketplace.

We have accepted all those recommendations. We will work in Health Canada and with our partners across the country to make it an even better system.

Health April 26th, 2001

Mr. Speaker, I thank the hon. member for his courtesy in raising this with my office and with me in advance of the question.

The member knows that this program is not administered by Health Canada. The court has appointed an arm's length administrator who is responsible. However, I share the frustration of the hon. member. I share the frustration of those who are entitled to money and who are not getting it. I have already written to the joint committee to express that frustration. I am working with that office and with the member's office to see what information we can get about this and other cases. We will continue to work to make sure these people get the money they are due.

Health April 26th, 2001

Mr. Speaker, we must never forget that this case involves the tragic loss of a 15 year old girl whose family will mourn her forever. Our hearts go out to them.

There are tragic lessons to be learned from this episode. We have received the recommendations of the jury. I have asked the deputy minister to examine them to find any way in which we can do our business better, to better serve Canadians and ensure their health.